Browse Gene Sets

Gene set name:

 

By first letter:

 

1 2 3 4 5 6 7 8 9 0 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

By collection:

[about the MSigDB collections]

  • H (hallmark gene sets, 50 gene sets)
  • C1 (positional gene sets, 326 gene sets)
  • C2 (curated gene sets, 4762 gene sets)
    • CGP (chemical and genetic perturbations, 3433 gene sets)
    • CP (Canonical pathways, 1329 gene sets)
    • CP:BIOCARTA (BioCarta gene sets, 217 gene sets)
    • CP:KEGG (KEGG gene sets, 186 gene sets)
    • CP:REACTOME (Reactome gene sets, 674 gene sets)
  • C3 (motif gene sets, 836 gene sets)
    • MIR (microRNA targets, 221 gene sets)
    • TFT (transcription factor targets, 615 gene sets)
  • C4 (computational gene sets, 858 gene sets)
    • CGN (cancer gene neighborhoods, 427 gene sets)
    • CM (cancer modules, 431 gene sets)
  • C5 (GO gene sets, 5917 gene sets)
    • BP (GO biological process, 4436 gene sets)
    • CC (GO cellular component, 580 gene sets)
    • MF (GO molecular function, 901 gene sets)
  • C6 (oncogenic signatures, 189 gene sets)
  • C7 (immunologic signatures, 4872 gene sets)

Gene sets starting with W

Click on a gene set name to view its gene set page.

WACKER_HYPOXIA_TARGETS_OF_VHL
WAESCH_ANAPHASE_PROMOTING_COMPLEX
WAGNER_APO2_SENSITIVITY
WAGSCHAL_EHMT2_TARGETS_UP
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUN
D_36HR

WAKABAYASHI_ADIPOGENESIS_PPARG_BOUN
D_8D

WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA
_BOUND_36HR

WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA
_BOUND_8D

WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA
_BOUND_WITH_H4K20ME1_MARK

WAKASUGI_HAVE_ZNF143_BINDING_SITES
WALLACE_JAK2_TARGETS_UP
WALLACE_PROSTATE_CANCER_DN
WALLACE_PROSTATE_CANCER_RACE_DN
WALLACE_PROSTATE_CANCER_RACE_UP
WALLACE_PROSTATE_CANCER_UP
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1
_2_DN

WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1
_2_UP

WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP
WANG_ADIPOGENIC_GENES_REPRESSED_BY_
SIRT1

WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAG
US_CANCER_DN

WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAG
US_CANCER_UP

WANG_BARRETTS_ESOPHAGUS_DN
WANG_BARRETTS_ESOPHAGUS_UP
WANG_CISPLATIN_RESPONSE_AND_XPC_DN
WANG_CISPLATIN_RESPONSE_AND_XPC_UP
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_
PPARG

WANG_CLIM2_TARGETS_DN
WANG_CLIM2_TARGETS_UP
WANG_ESOPHAGUS_CANCER_PROGRESSION_U
P

WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
WANG_HCP_PROSTATE_CANCER
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS
1_DN

WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS
1_UP

WANG_LMO4_TARGETS_DN
WANG_LMO4_TARGETS_UP
WANG_LSD1_TARGETS_DN
WANG_LSD1_TARGETS_UP
WANG_METASTASIS_OF_BREAST_CANCER
WANG_METASTASIS_OF_BREAST_CANCER_ES
R1_DN

WANG_METASTASIS_OF_BREAST_CANCER_ES
R1_UP

WANG_METHYLATED_IN_BREAST_CANCER
WANG_MLL_TARGETS
WANG_NEOPLASTIC_TRANSFORMATION_BY_C
CND1_MYC

WANG_NFKB_TARGETS
WANG_PROSTATE_CANCER_ANDROGEN_INDEP
ENDENT

WANG_RECURRENT_LIVER_CANCER_DN
WANG_RECURRENT_LIVER_CANCER_UP
WANG_RESPONSE_TO_ANDROGEN_UP
WANG_RESPONSE_TO_BEXAROTENE_DN
WANG_RESPONSE_TO_BEXAROTENE_UP
WANG_RESPONSE_TO_FORSKOLIN_DN
WANG_RESPONSE_TO_FORSKOLIN_UP
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB2
16763_DN

WANG_RESPONSE_TO_GSK3_INHIBITOR_SB2
16763_UP

WANG_RESPONSE_TO_PACLITAXEL_VIA_MAP
K8_DN

WANG_RESPONSE_TO_PACLITAXEL_VIA_MAP
K8_UP

WANG_SMARCE1_TARGETS_DN
WANG_SMARCE1_TARGETS_UP
WANG_TARGETS_OF_MLL_CBP_FUSION_DN
WANG_TARGETS_OF_MLL_CBP_FUSION_UP
WANG_THOC1_TARGETS_DN
WANG_THOC1_TARGETS_UP
WANG_TNF_TARGETS
WANG_TUMOR_INVASIVENESS_DN
WANG_TUMOR_INVASIVENESS_UP
WARTERS_IR_RESPONSE_5GY
WARTERS_RESPONSE_TO_IR_SKIN
WATANABE_COLON_CANCER_MSI_VS_MSS_DN
WATANABE_COLON_CANCER_MSI_VS_MSS_UP
WATANABE_RECTAL_CANCER_RADIOTHERAPY
_RESPONSIVE_DN

WATANABE_RECTAL_CANCER_RADIOTHERAPY
_RESPONSIVE_UP

WATANABE_ULCERATIVE_COLITIS_WITH_CA
NCER_DN

WATANABE_ULCERATIVE_COLITIS_WITH_CA
NCER_UP

WATTEL_AUTONOMOUS_THYROID_ADENOMA_D
N

WATTEL_AUTONOMOUS_THYROID_ADENOMA_U
P

WCAANNNYCAG_UNKNOWN
WCTCNATGGY_UNKNOWN
WEBER_METHYLATED_HCP_IN_FIBROBLAST_
DN

WEBER_METHYLATED_HCP_IN_FIBROBLAST_
UP

WEBER_METHYLATED_HCP_IN_SPERM_DN
WEBER_METHYLATED_HCP_IN_SPERM_UP
WEBER_METHYLATED_ICP_IN_FIBROBLAST
WEBER_METHYLATED_ICP_IN_SPERM_DN
WEBER_METHYLATED_ICP_IN_SPERM_UP
WEBER_METHYLATED_IN_COLON_CANCER
WEBER_METHYLATED_LCP_IN_FIBROBLAST_
DN

WEBER_METHYLATED_LCP_IN_FIBROBLAST_
UP

WEBER_METHYLATED_LCP_IN_SPERM_DN
WEBER_METHYLATED_LCP_IN_SPERM_UP
WEI_MIR34A_TARGETS
WEI_MYCN_TARGETS_WITH_E_BOX
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_
H2O2

WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_
TBH

WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_
H2O2

WEIGEL_OXIDATIVE_STRESS_RESPONSE
WEINMANN_ADAPTATION_TO_HYPOXIA_DN
WEINMANN_ADAPTATION_TO_HYPOXIA_UP
WELCH_GATA1_TARGETS
WELCSH_BRCA1_TARGETS_DN
WELCSH_BRCA1_TARGETS_UP
WENDT_COHESIN_TARGETS_UP
WENG_POR_DOSAGE
WENG_POR_TARGETS_GLOBAL_DN
WENG_POR_TARGETS_GLOBAL_UP
WENG_POR_TARGETS_LIVER_DN
WENG_POR_TARGETS_LIVER_UP
WEST_ADRENOCORTICAL_CARCINOMA_VS_AD
ENOMA_DN

WEST_ADRENOCORTICAL_CARCINOMA_VS_AD
ENOMA_UP

WEST_ADRENOCORTICAL_TUMOR_DN
WEST_ADRENOCORTICAL_TUMOR_MARKERS_D
N

WEST_ADRENOCORTICAL_TUMOR_MARKERS_U
P

WEST_ADRENOCORTICAL_TUMOR_UP
WESTON_VEGFA_TARGETS
WESTON_VEGFA_TARGETS_12HR
WESTON_VEGFA_TARGETS_3HR
WESTON_VEGFA_TARGETS_6HR
WGGAATGY_TEF1_Q6
WGTTNNNNNAAA_UNKNOWN
WHITE_NEUROBLASTOMA_WITH_1P36.3_DEL
ETION

WHITEFORD_PEDIATRIC_CANCER_MARKERS
WHITEHURST_PACLITAXEL_SENSITIVITY
WHITESIDE_CISPLATIN_RESISTANCE_DN
WHITESIDE_CISPLATIN_RESISTANCE_UP
WHITFIELD_CELL_CYCLE_G1_S
WHITFIELD_CELL_CYCLE_G2
WHITFIELD_CELL_CYCLE_G2_M
WHITFIELD_CELL_CYCLE_LITERATURE
WHITFIELD_CELL_CYCLE_M_G1
WHITFIELD_CELL_CYCLE_S
WHN_B
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PC
GF2

WIELAND_UP_BY_HBV_INFECTION
WIEMANN_TELOMERE_SHORTENING_AND_CHR
ONIC_LIVER_DAMAGE_DN

WIEMANN_TELOMERE_SHORTENING_AND_CHR
ONIC_LIVER_DAMAGE_UP

WIERENGA_PML_INTERACTOME
WIERENGA_STAT5A_TARGETS_DN
WIERENGA_STAT5A_TARGETS_GROUP1
WIERENGA_STAT5A_TARGETS_GROUP2
WIERENGA_STAT5A_TARGETS_UP
WIKMAN_ASBESTOS_LUNG_CANCER_DN
WIKMAN_ASBESTOS_LUNG_CANCER_UP
WILCOX_RESPONSE_TO_PROGESTERONE_DN
WILCOX_RESPONSE_TO_PROGESTERONE_UP
WILENSKY_RESPONSE_TO_DARAPLADIB
WILLERT_WNT_SIGNALING
WILLIAMS_ESR1_TARGETS_DN
WILLIAMS_ESR1_TARGETS_UP
WILLIAMS_ESR2_TARGETS_DN
WILLIAMS_ESR2_TARGETS_UP
WILSON_PROTEASES_AT_TUMOR_BONE_INTE
RFACE_DN

WILSON_PROTEASES_AT_TUMOR_BONE_INTE
RFACE_UP

WINNEPENNINCKX_MELANOMA_METASTASIS_
DN

WINNEPENNINCKX_MELANOMA_METASTASIS_
UP

WINTER_HYPOXIA_DN
WINTER_HYPOXIA_METAGENE
WINTER_HYPOXIA_UP
WINZEN_DEGRADED_VIA_KHSRP
WNT_SIGNALING
WNT_UP.V1_DN
WNT_UP.V1_UP
WONG_ADULT_TISSUE_STEM_MODULE
WONG_EMBRYONIC_STEM_CELL_CORE
WONG_ENDMETRIUM_CANCER_DN
WONG_ENDMETRIUM_CANCER_UP
WONG_ENDOMETRIAL_CANCER_LATE
WONG_IFNA2_RESISTANCE_DN
WONG_IFNA2_RESISTANCE_UP
WONG_MITOCHONDRIA_GENE_MODULE
WONG_PROTEASOME_GENE_MODULE
WOO_LIVER_CANCER_RECURRENCE_DN
WOO_LIVER_CANCER_RECURRENCE_UP
WOOD_EBV_EBNA1_TARGETS_DN
WOOD_EBV_EBNA1_TARGETS_UP
WORSCHECH_TUMOR_EVASION_AND_TOLEROG
ENICITY_DN

WORSCHECH_TUMOR_EVASION_AND_TOLEROG
ENICITY_UP

WORSCHECH_TUMOR_REJECTION_DN
WORSCHECH_TUMOR_REJECTION_UP
WOTTON_RUNX_TARGETS_DN
WOTTON_RUNX_TARGETS_UP
WOUND_HEALING
WTGAAAT_UNKNOWN
WTTGKCTG_UNKNOWN
WU_ALZHEIMER_DISEASE_DN
WU_ALZHEIMER_DISEASE_UP
WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
WU_CELL_MIGRATION
WU_HBX_TARGETS_1_DN
WU_HBX_TARGETS_1_UP
WU_HBX_TARGETS_2_DN
WU_HBX_TARGETS_2_UP
WU_HBX_TARGETS_3_DN
WU_HBX_TARGETS_3_UP
WU_SILENCED_BY_METHYLATION_IN_BLADD
ER_CANCER

WUNDER_INFLAMMATORY_RESPONSE_AND_CH
OLESTEROL_DN

WUNDER_INFLAMMATORY_RESPONSE_AND_CH
OLESTEROL_UP

WWTAAGGC_UNKNOWN
WYAAANNRNNNGCG_UNKNOWN